dihexa fda approval status 10MG : COA Tested Research peptide Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted FDA Peptide Update: Category 2 Removals Explained DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs DIHEXA CAPSULES High Purity Peptide for Laboratory Research
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


